On the Move with Haemophilia

“On the Move with Haemophilia”, an interactive educational programme developed by In Vivo Academy in collaboration with the Haemophilia Foundations of Australia and New Zealand, aims to improve the knowledge and confidence of parents, carers, and teachers in discussing and managing exercise for young people with haemophilia.

See more…

 
 

 

An update on Emerging Therapies for Cystic Fibrosis and Their Implications for Clinical Outcomes

This webcast, recorded during the 2018 European Cystic Fibrosis Society Conference in Belgrade, Serbia on 9 June 2018, features three international expert faculty and provides clinical perspectives of new and emerging clinical trials data on CFTR modulators presented at the conference, as well as insights on the implications of these data for people with CF.

See more…

 

New horizons in non-Hodgkin’s lymphoma

This webinar talks about important statistical concepts using recently published literature to evaluate the strengths, weaknesses, reproducibility (validity), and applicability of established and emerging endpoints in patients with non-Hodgkin’s lymphoma (NHL) and to assess relative efficacy between regimens or cohorts.

See more…

 

How Immune Checkpoint Inhibitors Are Changing the Treatment Landscape for Metastatic Melanoma

This webinar, a recording of the satellite symposium at the 9th World Congress of Melanoma held in Brisbane, Australia last 20 October 2017, covers the current practices and challenges in management of metastatic melanoma, as well as insights on the future management of melanoma patients.

See more…

 

Aerosolized Agents for Airway Clearance in Cystic Fibrosis: When, How and Why

This webinar is a roundtable discussion among three international expert faculty on the role of aerosolized agents for improving airway clearance, including caveats from their own extensive clinical experience in managing patients with cystic fibrosis (CF). Using case studies, the faculty also deliberates on strategies to improve patient adherence to CF therapy.

See more…

 

 

Free

MOTIVATE Course 1: Definition and Pathophysiology of MOH

Did you know that excessive use of acute headache medications may be the culprit for frequent headaches? Learn about MOH, its diagnostic criteria and pathophysiology, and the medications associated with it.

See more...

Free

MOTIVATE Course 2: History Taking, Diagnosing, and Treatment of MOH

Taking a proper history plays a big part in diagnosing headache. Physical examination and laboratory testing only rarely offer diagnostic clues. Using a simulated case study, recall the process of detailed history taking to elicit ...

See more...

Free

MOTIVATE Course 3: Prevention of MOH

Treatment of MOH may be difficult, and so it is important for patients to understand how to prevent this condition in the first place. As a healthcare professional, learn how to recognise patients at risk of MOH and educate them on how to avoid falling into the cyclical trap of overusing their headache medications.

See more...

Free

MOTIVATE Course 4: Behavioural Aspects of MOH

MOH is said to be a biobehavioural disorder, wherein patients believe that they need their headache medication to function. Comorbid psychiatric disorders are also common among these patients. Learn about strategies for patient education and individualising management.

See more...